Russell Investments Group’s scPharmaceuticals SCPH Stock Holding History

Russell Investments Group’s Portfolio SCPH Stock Details SCPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-3,743	Closed	-$21.2K	–	4248
2025 Q3	$21.2K	Buy	3,743 +3,063	+450%	+$15.7K	﹤0.01%	3578
2025 Q2	$2.59K	Buy	680 +359	+112%	+$1.11K	﹤0.01%	3560
2025 Q1	$844	Buy	+321	New	+$1.05K	﹤0.01%	3610
2024 Q4	–	Sell	-449	Closed	-$2.05K	–	3780
2024 Q3	$2.05K	Buy	449 +405	+920%	+$1.96K	﹤0.01%	3371
2024 Q2	$191	Buy	+44	New	+$193	﹤0.01%	3549
2023 Q4	–	Sell	-35	Closed	-$249	–	3295
2023 Q3	$249	Buy	+35	New	+$276	﹤0.01%	3465
2021 Q3	–	Sell	-194,238	Closed	-$1.19M	–	3191
2021 Q2	$1.19M	Buy	+194,238	New	+$1.17M	﹤0.01%	2232

Russell Investments Group's SCPH Position: Q4 2025 in Review

Russell Investments Group sold out of scPharmaceuticals (SCPH) in Q4 2025, closing a stake of 3,743 shares — an estimated $21.2K sold.

Russell Investments Group first reported a position in SCPH in Q2 2021 and held it in 7 quarters. The position peaked at $1.19M in Q2 2021. 0 funds tracked by Wall St. Rank hold SCPH as of Q4 2025.

Russell Investments Group reported no remaining scPharmaceuticals position as of Q4 2025 after selling out during the quarter.
Russell Investments Group sold 3,743 scPharmaceuticals shares in Q4 2025, an estimated $21.2K.
Russell Investments Group first reported a position in scPharmaceuticals in Q2 2021 and held it in 7 quarters.
Russell Investments Group's scPharmaceuticals position peaked at $1.19M in Q2 2021.
0 funds tracked by Wall St. Rank held scPharmaceuticals as of Q4 2025.

Based on Russell Investments Group's 13F filing for Q4 2025, filed 17 Feb 2026.